Print

IAVI 009

Phase I double blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of one or two doses of an HIV-1 Clade A DNA vaccine followed by an HIV-1 Clade A MVA boost.

Trial Details:

I Completed
Uganda Virus Research Institute January 13, 2003
DNA.HIVA ,MVA.HIVA Pox Gag A; DNA Gag A
DNA.HIVA DNA
MVA.HIVA Viral Vector - Pox
Uganda 50
http://www.iavi.org